PERSPECTA

News from every angle

← Back to headlines

Nuvation Bio Acquires Global Rights for Brain Cancer Therapy

Nuvation Bio has secured global rights from Daiichi Sankyo for a new brain cancer therapy, expanding its portfolio in oncology.

1 Apr, 13:01 — 1 Apr, 13:01
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed147d ago

Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo

Read full article →

Related Stories

Busy Philipps Reveals Rare Brain Tumor Diagnosis and Successful Surgery

52m ago

FDA Approves Breakthrough Oral Treatment for Pancreatic Cancer

1h ago

WHO Declares End of Ebola Outbreak in Uganda Amid Rising Cases in Congo

2h ago

Nutritionists Explain How Dietary Fiber Can Improve Sleep Quality

3h ago